# Study of Promethazine for Treatment of Diabetic Gastroparesis

> **NCT02130622** · PHASE2 · TERMINATED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 3 (actual)

## Conditions studied

- Diabetic Gastroparesis

## Interventions

- **DRUG:** Promethazine
- **DRUG:** Sugar pill

## Key facts

- **NCT ID:** NCT02130622
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-07
- **Primary completion:** 2015-05-14
- **Final completion:** 2015-05-14
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Lack of recruitment
- **Last updated:** 2018-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02130622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02130622, "Study of Promethazine for Treatment of Diabetic Gastroparesis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02130622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*